Souza, Luiz Paulo Chaves; Costa, André Luiz Caliari 
; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: Proceedings of the American Association for Cancer Research Annual Meeting. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, MUTAÇÃO GENÉTICA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves et al. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-1818. Acesso em: 14 ago. 2024. , 2021APA
Souza, L. P. C., Costa, A. L. C., Melo, C. M., Saggioro, F. P., & Squire, J. A. (2021). ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-1818NLM
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 ago. 14 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818Vancouver
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 ago. 14 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
